Ward 24/7 develops a wireless assessment of respiratory and circulatory distress to monitor and observe high-risk patients.
Ward 24/7 has raised $3.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Ward 24/7's investors include BioInnovation Institute, Innovestor, Export and Investment Fund, Sagitta Ventures.
Ward 24/7 is headquartered in Copenhagen, Denmark.
Ward 24/7 develops a wireless assessment of respiratory and circulatory distress to monitor and observe high-risk patients.
Ward 24/7 is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ward 24/7 — Funding & Investors." VCBacked, January 19, 2024, https://www.vcbacked.co/company/ward-247. Accessed August 14, 2026.
VCBacked. (2024). Ward 24/7 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ward-247
{{cite web |title=Ward 24/7 — Funding & Investors |url=https://www.vcbacked.co/company/ward-247 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated